Foxo4-DRI from Pharma Lab Global ASIA is a peptide that operates by interrupting the interaction between FOXO4 and p53, two proteins that play crucial roles in cellular ageing and senescence. This interaction prompts senescent cells to self-destruct, a process known as apoptosis. Thus, Foxo4-DRI has been a significant focus for research in age-related diseases and the pursuit of understanding cellular longevity. Foxo4-Dri from Pharma Lab Global ASIA is available in vials, pre-mixed pens, and nasal sprays, that offer versatile options for research applications.
TO PURCHASE PRODUCTS FROM OUR WEBSITE YOU MUST BE AT LEAST 21 YEARS OF AGE.
DISCLAIMER: All products sold by Pharma Lab Global are for in-vitro research and laboratory use only. These products are not designed for use or consumption by humans or animals. Nothing on this Website is intended to diagnose, heal, treat, cure, mitigate or prevent disease. By purchasing from our Website the buyer accepts and acknowledges the risks involved with consumption and handling of these products. All articles and product information provided on this Website are for informational and educational purposes only. All products are to be handled by qualified and properly trained research or laboratory professionals only.